Lord, Abbett & Co
TRAW icon

Lord, Abbett & Co’s Traws Pharma TRAW Stock Holding History

Lord, Abbett & Co’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3
Closed -$5.19M – 1100
2013
Q3 		$5.19M Buy
+3
New +$4.29M 0.01% 788

Other funds holding TRAW

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WC
Weatherbie Capital Boston, Massachusetts $797M AUM 23.31% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co's TRAW Position: Q4 2013 in Review

Lord, Abbett & Co sold out of Traws Pharma (TRAW) in Q4 2013, closing a stake of 3 shares — an estimated $5.19M sold.

Lord, Abbett & Co first reported a position in TRAW in Q3 2013 and held it in 1 quarter. The position peaked at $5.19M in Q3 2013. 17 funds tracked by Wall St. Rank hold TRAW as of Q4 2013.

  • Lord, Abbett & Co reported no remaining Traws Pharma position as of Q4 2013 after selling out during the quarter.
  • Lord, Abbett & Co sold 3 Traws Pharma shares in Q4 2013, an estimated $5.19M.
  • Lord, Abbett & Co first reported a position in Traws Pharma in Q3 2013 and held it in 1 quarter.
  • Lord, Abbett & Co's Traws Pharma position peaked at $5.19M in Q3 2013.
  • 17 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2013.

Based on Lord, Abbett & Co's 13F filing for Q4 2013, filed 14 Feb 2014.